Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
dexverapamil
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of R-VPAM/DOX for Recurrent Sarcomas (Summary Last Modified 09/95)
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
any age
Sponsor:
NCI
Protocol IDs:
CCF-IRB-1105
, NCI-T94-0167D, T94-0167
2.
Phase I/II Study of R-Verapamil with EPOCH (VP-16/PRED/VCR/CTX/DOX), with Analysis of Drug Resistance Mechanisms, in Relapsed/Refractory Lymphomas and Pediatric Sarcomas and of EPOCH Alone in Previously Untreated HIV-Associated Lymphomas (Summary Last Modified 01/96)
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Completed
Age:
at least 1 year
Sponsor:
NCI
Protocol IDs:
NCI-90-C-0113E
, NCI-MB-255, NCI-T90-0047N, T90-0047
3.
Phase II Study of Paclitaxel with the Multidrug Resistance Modulator Dexverapamil for Metastatic Breast Cancer (Summary Last Modified 06/95)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
TCINJ-940-1529
, NCI-T94-0122O, T94-0122
4.
Phase II Study of VBL with Dexverapamil for Metastatic Renal Cell Cancer (Summary Last Modified 01/95)
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
over 18
Sponsor:
Protocol IDs:
MSKCC-91120
, NCI-V92-0024
5.
Phase II Pilot Study of Continuous-Infusion VIDA (VP-16/IDA/ARA-C) with or without R-Verapamil in Patients with Secondary AML or DeNovo AML in Relapse (Summary Last Modified 06/93)
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-92-C-0241
, NCI-MB-296, NCI-T92-0085N, T92-0085
6.
Phase I Study of TAX with R-VPAM and G-CSF in Patients with Previously Treated, Metastatic Breast Cancer (Summary Last Modified 11/94)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-92-C-0245K
, NCI-MB-301, NCI-T92-0118N, T92-0118
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute